Stock Comparison
ARGX vs NUVB
argenx NV ADR and Nuvation Bio Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$2.14B
P/E (TTM)
32.7
—
Forward P/E
30.4
—
Price/Sales
10.0
12.6
Price/Book
6.4
8.5
EV/EBITDA
27.6
2.1
Dividend Yield
—
—
Profitability
Net Margin
30.44%
-102.06%
Operating Margin
27.34%
-104.99%
Return on Equity
23.60%
-47.80%
Return on Assets
11.60%
-12.40%
Growth (YoY)
Revenue Growth
59.30%
556.00%
Earnings Growth
95.20%
0.00%
Price & Risk
Beta
-0.0
1.5
52-Week High
$939.68
$9.54
52-Week Low
$652.43
$2.69
Analyst Target
$1,085.78
$12.89
Compare ARGX and NUVB your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.